Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

467
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
467
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

477
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
477

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Structural and functional benchmarking of monolayer- and bioreactor-generated hiPSC-derived cardiomyocytes.

APL bioengineering·2026
Same author

Loss of WNT2B Increases Tumor Burden and Malignant Features in Colorectal Cancer.

Cancer communications (London, England)·2026
Same author

SORBS2 regulates diastolic function through cytoskeletal networks and calcium handling.

Communications biology·2026
Same author

Placental Evidence of Intrauterine Stress: Mechanisms, Timing, and Links to Perinatal Brain Injury.

Journal of clinical medicine·2026
Same author

Drug Induced Liver Injury in Children: Practical Considerations for Pathologists.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same author

Childhood-Onset Desmin-Related Cardiomyopathy: Comprehensive Clinical, Histopathological, Immunohistochemical, Ultrastructural, and Molecular Characterization.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026

相关实验视频

Updated: Jun 16, 2025

Pull-down of Calmodulin-binding Proteins
07:51

Pull-down of Calmodulin-binding Proteins

Published on: January 23, 2012

25.3K

抗意义寡核酸治疗卡尔莫杜林病

Raul H Bortolin1, Farina Nawar1, Chaehyoung Park1

  • 1Department of Cardiology (R.H.B., F.N., C.P., M.A.T., M.P., M.E.S., P.W., J.C., F.L., C.L., P.B., E.M.K., D.Y., N.P., T.S., Q.M., D.J.A., V.J.B., W.T.P.).

Circulation
|August 19, 2024
PubMed
概括

针对特定卡尔莫杜林基因的反感性寡核酸 (ASO) 显示为治疗遗传性心律失常综合征的前景. 这种方法有效地使模型中的心脏功能正常化,而不会影响基本的卡尔莫杜林水平.

关键词:
没有意义的寡核酸没有长时间QT综合征精准医学快速心跳,心室

更多相关视频

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.6K
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

13.4K

相关实验视频

Last Updated: Jun 16, 2025

Pull-down of Calmodulin-binding Proteins
07:51

Pull-down of Calmodulin-binding Proteins

Published on: January 23, 2012

25.3K
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.6K
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

13.4K

科学领域:

  • 心血管遗传学
  • 分子心脏病学
  • 遗传医学

背景情况:

  • 卡尔莫杜林病是一种罕见的遗传性心律失常综合征.
  • 这些情况源于CALM1,CALM2或CALM3基因中占主导地位的异构变异,这些基因编码了calmodulin (CaM) 蛋白质.
  • 这些基因中的 CaM 蛋白质的相同性质构成了治疗挑战.

研究的目的:

  • 测试一种假设,即受影响的calmodulin基因的反意义寡核酸 (ASO) 中介性耗尽可以改善疾病的表现.
  • 为了确定其他calmodulin基因是否可以在目标耗尽期间保持CaM水平和功能.
  • 探索ASOs作为一种潜在的治疗策略.

主要方法:

  • 使用人类诱导的多能干细胞衍生心肌细胞 (hiPSC-CMs) 和携带CALM1病原型的小鼠模型.
  • 针对hiPSC-CMs中的CALM1和小鼠中的CALM1的ASOs.
  • 对动力潜能持续时间,再极化,CaM蛋白水平,转录水平以及心电和收缩功能进行了评估.

主要成果:

  • 人类CALM1变异的hiPSC- CM表现出延长的作用潜力,模拟先天的长QT综合征.
  • 在受影响的hiPSC- CM中,CALM1- 耗尽的ASOs在不改变CaM蛋白水平的情况下使复极化正常化.
  • 针对小鼠的ASO降低了Calm1的转录,缓解了小鼠的药物诱导的心室动脉障,并没有损害心脏功能.

结论:

  • 证明了ASO介导的治疗概念.
  • 针对单个卡尔莫杜林基因的ASOs是潜在的有效治疗方法.
  • 这种治疗策略似乎是安全的, 保持整体的CaM水平和心脏功能.